Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Pei Fan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6592-3071; OpenAlex author ID A5021433151. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: 3 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 7

  1. Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. Co-author DOI 10.18632/oncotarget.28527↗
  2. microRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancer. First author DOI 10.1016/j.canlet.2016.11.035↗
  3. MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2016.01.038↗
  4. Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy. Co-author DOI 10.1038/cddis.2016.157↗
  5. Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.7031↗
  6. Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. Co-author DOI 10.18632/oncotarget.3171↗
  7. Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. Co-author DOI 10.18632/oncotarget.2120↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ingrid Herr · 7 shared papers, 2014–2024 · strength 0.49
  2. Nathalie Bauer · 6 shared papers, 2014–2024 · strength 0.44
  3. Yiyao Zhang · 4 shared papers, 2014–2024 · strength 0.31
  4. Li Liu · 3 shared papers, 2015–2024 · strength 0.28
  5. Alexandr V. Bazhin · 3 shared papers, 2014–2024 · strength 0.26
  6. Nathalia A. Giese · 2 shared papers, 2015–2024 · strength 0.23
  7. Eduard Ryschich · 2 shared papers, 2015–2024 · strength 0.23
  8. Franco Fortunato · 2 shared papers, 2015–2024 · strength 0.23
  9. Thilo Hackert · 2 shared papers, 2015–2024 · strength 0.23
  10. Oliver Strobel · 2 shared papers, 2015–2024 · strength 0.23
  11. Clifford C. Nwaeburu · 3 shared papers, 2014–2016 · strength 0.14
  12. Prince Saforo Amponsah · 2 shared papers, 2016–2017 · strength 0.13
  13. Yefeng Yin · 2 shared papers, 2016 · strength 0.10
  14. Peter Schemmer · 2 shared papers, 2016 · strength 0.10
  15. Adam Kaczorowski · 1 shared paper, 2016 · strength 0.05
  16. Alia Abukiwan · 1 shared paper, 2016 · strength 0.05
  17. Xi Xiao · 1 shared paper, 2016 · strength 0.05
  18. Orkhan Isayev · 1 shared paper, 2014 · strength 0.03
  19. Felix Rückert · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.